* Chromadex Corp is expected to show a rise in quarterly revenue when it reports results on October 31 for the period ending January 1 0001

* The Los Angeles California-based company is expected to report a 21.3% increase in revenue to $23.643 million from $19.5 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

* ​LSEG's mean analyst estimate for Chromadex Corp is for breakeven results per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Chromadex Corp is 6.35​, above​ its last closing price of $3.67. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Jan. 1 0001 -0.02 -0.02 0.00 Beat 100

Jan. 1 0001 -0.02 -0.02 -0.01 Beat 40

Jan. 1 0001 -0.03 -0.03 0.00 Beat 100​

Sep. 30 2023 -0.03 -0.03 -0.01 Beat 69.2

​​Jan. -0.04 -0.04 -0.03 Beat 20

1 0001

Mar. 31 2023 -0.05 -0.05 -0.03 Beat 37.5​

Dec. 31 2022 -0.03 -0.02 -0.02 Met 17.3

Sep. 30 2022 -0.06 -0.06 -0.04 Beat 35.5

This summary was machine generated October 29 at 21:05 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)